Inflammatory bowel diseases are gastrointestinal diseases that include Crohn disease and ulcerative colitis. The chronic inflammation is thought to result from an excessive inflammatory response to environmental factors such as luminal bacteria in genetically predisposed individuals. Studies have revealed that mice with impaired vitamin D signaling are more susceptible to experimental colitis. I nflammatory bowel diseases (IBDs) represent a group of idiopathic, chronic diseases of the gastrointestinal tract that include Crohn disease and ulcerative colitis. The exact etiology of IBD is still largely unknown; however, it is generally accepted that an excessive host immune response toward luminal bacteria plays a major role. Moreover, genetic and environmental factors and the epithelial barrier itself are involved in the pathogenesis of IBD. Vitamin D 3 deficiency is common in IBD patients, as measured by 25(OH)D 3 serum concentrations. Low vitamin D 3 levels are associated with decreased health-related quality of life (1, 2) and with more severe disease activity in IBD patients (1, 3, 4) . Most vitamin D 3 is generated in human skin under the influence of sunlight. To obtain its biologically active form, 1a,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ], vitamin D 3 undergoes two subsequent hydroxylations in the liver and kidneys. In addition to the systemic production of 1,25(OH) 2 D 3 , several cell types are capable of 1,25(OH) 2 D 3 generation, which is important for local autocrine and paracrine actions. 1,25(OH) 2 D 3 then binds the vitamin D receptor (VDR), which functions as a transcription factor to modulate gene expression. Systemic deletion of the VDR renders mice more susceptible to chemically induced colitis (5), and 1,25(OH) 2 D 3 treatment is able to ameliorate colitis-associated
Inflammatory bowel diseases are gastrointestinal diseases that include Crohn disease and ulcerative colitis. The chronic inflammation is thought to result from an excessive inflammatory response to environmental factors such as luminal bacteria in genetically predisposed individuals. Studies have revealed that mice with impaired vitamin D signaling are more susceptible to experimental colitis. To better understand the contribution of vitamin D signaling in different cells of the gut to this disease, we investigated the effects of intestinal-specific or myeloid vitamin D receptor deletion. Our study addressed the importance of vitamin D receptor expression in intestinal epithelial cells using intestine-specific vitamin D receptor null mice and the contribution of vitamin D receptor expression in macrophages and granulocytes using myeloid-specific vitamin D receptor null mice in a dextran sodium sulfate model for experimental colitis. Loss of intestinal vitamin D receptor expression had no substantial effect on the clinical parameters of colitis and did not manifestly change mucosal cytokine expression. Inactivation of the vitamin D receptor in macrophages and granulocytes marginally affected colitis-associated symptoms but resulted in increased proinflammatory cytokine and increased b-defensin-1 expression in the colon descendens of mice with colitis. Intestinal deletion of the vitamin D receptor did not aggravate symptoms of chemically induced colitis. Loss of the vitamin D receptor in macrophages and granulocytes mildly affected colitis-associated symptoms but greatly increased proinflammatory cytokine expression in the inflamed colon, suggesting a prominent role for innate immune cell vitamin D signaling in controlling gut inflammation. (Endocrinology 158: 2354-2366, 2017) I nflammatory bowel diseases (IBDs) represent a group of idiopathic, chronic diseases of the gastrointestinal tract that include Crohn disease and ulcerative colitis. The exact etiology of IBD is still largely unknown; however, it is generally accepted that an excessive host immune response toward luminal bacteria plays a major role. Moreover, genetic and environmental factors and the epithelial barrier itself are involved in the pathogenesis of IBD. Vitamin D 3 deficiency is common in IBD patients, as measured by 25(OH)D 3 serum concentrations. Low vitamin D 3 levels are associated with decreased health-related quality of life (1, 2) and with more severe disease activity in IBD patients (1, 3, 4) . Most vitamin D 3 is generated in human skin under the influence of sunlight. To obtain its biologically active form, 1a,25-dihydroxyvitamin D 3 [1, 25(OH) 2 D 3 ], vitamin D 3 undergoes two subsequent hydroxylations in the liver and kidneys. In addition to the systemic production of 1,25(OH) 2 D 3 , several cell types are capable of 1,25(OH) 2 D 3 generation, which is important for local autocrine and paracrine actions. 1,25(OH) 2 D 3 then binds the vitamin D receptor (VDR), which functions as a transcription factor to modulate gene expression. Systemic deletion of the VDR renders mice more susceptible to chemically induced colitis (5) , and 1,25(OH) 2 D 3 treatment is able to ameliorate colitis-associated symptoms (6, 7) ; this illustrates the importance of vitamin D 3 and its receptor during experimental IBD. Several studies have shown that 1,25(OH) 2 D 3 can strengthen the epithelial barrier by increasing the expression of different tight junction proteins (7, 8) . Moreover, 1,25(OH) 2 D 3 has many immunomodulatory effects in different immune cell types, including inhibition of proinflammatory cytokine production, enhanced phagocytosis by macrophages, and induction of tolerogenic dendritic cells and regulatory T-cells (9) . Therefore, studying the role of vitamin D 3 and its receptor specifically in the intestinal epithelium and innate immune cells during gut inflammation might provide insights on the protective effects of vitamin D 3 in IBD. In the present study, we used systemic, intestinal-specific and myeloid cell-specific Vdr knockout (KO) mice to decipher the role of intestinal and myeloid VDR expression during gut inflammation in dextran sodium sulfate (DSS)-induced colitis. As previously demonstrated, systemic Vdr KO mice are more susceptible to DSS-induced colitis. However, mice with a specific deletion of the Vdr in intestinal epithelial cells (IECs) did not exhibit exacerbation of DSS-induced colitis, and mice with a myeloid-specific Vdr deletion demonstrated a mild aggravation of DSS-associated symptoms. Additionally, myeloid-specific Vdr deletion increased the expression of several proinflammatory cytokines and the antimicrobial peptide b-defensin-1 (Defb1) in the gut.
Materials and Methods

Ethical considerations
All mice were housed in an animal room with 12-hour dark/ light cycles and a constant temperature. Food and water were supplied ad libitum. The ethical committee of the University of Leuven approved all animal experiments (project nos., 003/ 2009 and 228/2013).
Transgenic mouse models
Systemic VDR KO mice (Vdr 2/2 ) on the Leuven genetic background were generated by crossing Vdr fl/fl mice (10) with phosphoglycerate kinase-Cre mice (11) . VDR wild-type (WT) (Vdr +/+ ) littermates were used as controls. Intestinal-specific VDR KO mice (Vdr int2 ) on the Leuven background were generated by crossing Vdr fl/fl mice with villin-Cre mice, as previously described (12) . Vdr fl/fl;cre2 littermates (Vdr int+ ) were used as controls. To obtain myeloid-specific VDR KO mice (Vdr myel2 ), Vdr fl/fl mice on the Leuven background were mated with LysM-Cre mice (13) and Vdr int+ , respectively). All mice used in the present study consumed a rescue diet (2% calcium, 1.25% phosphate, 20% lactose; Sniff S8655-E060, Soest, Germany) after weaning to normalize calcium levels.
Induction of colitis
Acute experimental colitis was induced in 8-to 10-week-old mice (males and females) by administration of 2.5% DSS (36,000 to 50,000 molecular weight; MP Biologicals, Santa Ana, CA) in the drinking water for 6 days. Afterward, the mice received normal drinking water for the remainder of the experiment and were euthanized on day 7 or day 10. The control mice received normal drinking water throughout the experiment. At the end of the experiment, mucosa from the proximal (colon ascendens) and distal (colon descendens) parts of the colon was isolated and frozen at 280°C. The colon length was measured between the colon-cecal junction and the distal rectum.
Disease activity index evaluation
The disease activity index (DAI) was assessed by daily measurement of body weight (BW), stool consistency, and gross bleeding and was calculated as follows. For BW, the possible scores were 0, no BW loss; 1, ,5% BW loss; 2, 5% to 10% BW loss; 3, 10% to 15% BW loss; and 4, .15% BW loss. For stool consistency, the possible scores were 0, normal stool; 1, soft pellets; 2, liquid stool; and 3, diarrhea. Finally, for gross bleeding, the possible scores were 0, no blood in Hemoccult test; 1, positive Hemoccult test after 30 seconds; 2, immediate Hemoccult reaction; and 3, gross bleeding from the rectum. The presence of blood in the stool was assessed using the Hemoccult Sensa kit (Beckman Coulter, Brea, CA). The DAI scores varied from 0 (no symptoms) to 10 (severe colitis symptoms).
Serum calcium measurements
Serum calcium levels were determined using the Olympus AU640 chemistry analyzer (Beckman Coulter, Brea, CA) and the Arsenazo III method.
Histopathology
The resected colon was fixed overnight in 4% freshly prepared paraformaldehyde solution and embedded in paraffin. For histopathologic analysis, tissue sections (4 mm) were stained with hematoxylin and eosin for 2 minutes and 30 seconds, respectively. Microscopic sections were graded by the number and severity of lesions using a previously described scoring system (15) . The length of the lesions with acute inflammation or regenerating mucosa was measured and expressed as the percentage of affected tissue of the total colon length. 
Isolation of peritoneal macrophages
Bacterial load measurement
Total DNA was isolated from frozen colon descendens mucosa samples using the DNA Mini kit (Qiagen, Hilden, Germany) following the recommendations of the manufacturer. A fraction of the isolated DNA was then used for detection of bacterial 16S ribosomal DNA via real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Eukaryotic 18S ribosomal DNA was used to normalize the expression levels of each sample. The relative amount of 16S ribosomal DNA in each sample was estimated using the 2 2DDCt method.
Quantitative real-time PCR
Freshly dissected tissue from the colon ascendens and colon descendens was snap-frozen, and RNA was extracted in TRIzol (Invitrogen, Carlsbad, CA) followed by chloroform/ isopropanol purification. RNA isolation from peritoneal macrophages was performed with the High Pure RNA isolation kit following the manufacturer's instructions (Roche, Basel, Switzerland). Complementary DNA was synthesized from equal amounts of RNA with reverse transcription SuperScript II RT (Invitrogen, Carlsbad, CA). Gene expression was assessed by qRT-PCR using Fast SYBR Master mix or TaqMan Fast Universal PCR master mix in a 7500 Fast sequence detector system (Applied Biosystems, Foster City, CA). Expression of the gene of interest (Table 1 ) was normalized to the expression of b-actin, and the 2 2DDCt method was used to calculate the relative gene expression. All qRT-PCR reactions were performed in triplicate.
Western blot
Samples were homogenized in radioimmunoprecipitation assay buffer [50 mM Tris HCl, pH 8.0, 300 mM NaCl, 0.1% sodium dodecyl sulfate, 1% Triton X-100, 0.5% Nadeoxycholate, 13 Halt proteinase inhibitor cocktail (Thermo Fisher Scientific Life Sciences, Waltham, MA)], and the protein concentration was determined using the bicinchoninic acid assay method (Pierce BCA protein assay kit; Thermo Fisher Scientific Life Sciences, Waltham, MA). Equal amounts of protein were loaded on 4% to 12% Bis-Tris sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (Thermo Fisher Scientific Life Sciences) and transferred to a nitrocellulose blotting membrane (Amersham Hybond ECL; GE Healthcare, Little Chalfont, UK). Blots were incubated at room temperature for 1 hour with 5% nonfat dry milk in Tris-buffered saline-0.1% Tween to block nonspecific binding, followed by overnight incubation at 4°C with the primary antibody (VDR, 1/500; Cell Signaling Technology, Danvers, MA; catalog no. 12550, Research Resource Identifier, AB_2637002; b-actin (1/5000; Sigma-Aldrich; catalog no. A5441; Research Resource Identifier, AB_476744). After incubation with the appropriate secondary horseradish peroxidase-conjugated antibody (Dako, Glostrup, Denmark) blots were developed using enhanced chemiluminescence (Western Lightning; Perkin Elmer, Waltham, MA) and the ImageQuant LAS 500 (GE Healthcare, Little Chalfont, UK).
Statistical analysis
All statistical analyses were performed with Prism, version 7.0 (GraphPad Software, La Jolla, CA). Data are expressed as the mean 6 standard error of the mean. To analyze changes in the percentage of BW loss and DAI over time, the area under the curve was calculated for each mouse. Differences between two groups were analyzed using the Mann-Whitney U test. qRT-PCR data were analyzed using two-way analysis of variance, followed by a Tukey multiple comparisons test. Differences were considered statistically significant at P , 0.05.
Results
Myeloid, but not intestinal, deletion of Vdr aggravates clinical symptoms of acute experimental colitis
To verify that Vdr deletion was restricted to either the intestine or myeloid cells, several tissues of Vdr , and Vdr myel+ mice were investigated for Vdr expression using qRT-PCR. Vdr transcript levels were significantly lower in Vdr int2 mice, both in the colon ascendens and the colon descendens. Western blot of intestinal mucosa samples confirmed VDR deletion in both Leuven and Tokyo Vdr int2 mice [ Fig. 1 (a) and 1(b) and Supplemental Fig. 1A ]. Myeloid Vdr deletion (approximately 80%) was confirmed by messenger RNA transcript levels and Western blot [ Fig. 1(d) and 1(e) ]. Furthermore, Fig. 2(a) ] and lost significantly more BW [P , 0.05; Fig. 2(d) ], as measured by the area under the curve from the primary data curves [Supplemental Fig. 2A and  2D] . Furthermore, the colon length of Vdr 2/2 mice (7. Histologic evaluation of the complete colon ("Swiss roll") of mice euthanized at day 7 revealed substantial changes in the gut of mice with colitis compared with that of healthy mice (Fig. 3) . The histologic changes associated with acute inflammation included enlarged crypt lumens, loss of crypts and goblet cells, infiltration of neutrophils, and ulcer formation. Longer lasting colitis with partial mucosal regeneration ( Fig. 3 ; white arrows) was characterized by abnormal crypt architecture with branching and/or shortening of crypts, variation in intercrypt spacing, and increased mononuclear cell infiltrate. Areas of acute inflammation and regeneration were measured in Vdr In accordance with our previous observations of clinical parameters, no differences in acute inflammation, regeneration, or ulceration were detected between Vdr int2 and Vdr int+ littermates [ Fig. 4(b) , 4(e), 4(h), and 4(k)]. Also, in Vdr myel2 mice we did not observe statistically significant differences in acute inflammation, regeneration, or ulceration compared with the Vdr myel+ mice [ Fig. 4 (c), 4(f), 4(i), and 4(l)]. Thus, deletion of Vdr in epithelial intestinal cells did not aggravate clinical symptoms; however, mice with a Vdr deletion in macrophages and granulocytes showed a mild aggravation of the clinical parameters in our model of DSS-induced colitis, although not to the extent in the systemic Vdr KO mice.
Myeloid Vdr expression tempers mucosal cytokine expression during experimental colitis
Because Vdr deletion in IECs or myeloid cells did not strongly aggravate the clinical symptoms of DSS-induced colitis, we examined the effects of intestinal or myeloid Vdr deletion on proinflammatory gene expression in the mucosa of healthy and inflamed colon. All tested inflammatory markers were upregulated in the colon descendens after DSS insult. Tnf-a expression was significantly greater in the colon descendens of Vdr 2/2 mice after DSS insult compared with their Vdr +/+ littermates [P , 0.05; Fig. 5(a) ]. The transcript levels of other tested proinflammatory cytokines tended to be greater in Vdr 2/2 mice than in Vdr +/+ mice with colitis; however, and Vdr myel+ mice at day 10 after DSS-induced colitis. Results are expressed as mean 6 standard error of mean (n $ 13). *P , 0.05. these differences were not statistically significant. No substantial changes in proinflammatory cytokine expression were observed in the colon descendens of Vdr int2 mice compared with their Vdr int+ littermates with colitis; however, transcript levels of several cytokines tended to be elevated in the Vdr int2 mice [ Fig. 5 (b) and 5(e) and Fig. 6(b), 6 (e), and 6(h)]. In contrast, we observed a substantial increase in Ifn-g and Il-6 expression in the colon descendens of Vdr myel2 mice compared with their Vdr myel+ littermates after DSS insult [P , 0.05; Fig. 5 (f) and Fig. 6(f) ]. Also Il-1b transcript levels tended to be increased in the colon descendens of mice with a Vdr deletion in macrophages and granulocytes during colitis [P = 0.054; Fig. 6(c) Fig. 6(g) and 6(h) ].
Intestinal or myeloid deletion of Vdr does not alter glutathione peroxidase-2 expression in the colon during experimental colitis
The gastrointestinal tract is an important source of reactive oxygen and nitrogen species production. Enzymes such as glutathione peroxidase (GPx) are part of the antioxidant defense system responsible for the elimination of reactive species (16) . GPx-2 has epithelium-specific expression and is responsible for most hydrogen peroxide-reducing activity in the gastrointestinal tract (17) . The difference in mucosal expression of Gpx-2 in the Vdr 2/2 , Vdr int2 , or Vdr myel2 compared with their WT littermates was not statistically significant ( Fig. 7) , neither in healthy mice nor after DSS insult. However, Gpx-2 expression tended to be greater in the colon descendens of Vdr 2/2 and Vdr int2 mice with colitis compared with their WT littermates.
Antimicrobial defense in the gut mucosa is affected by myeloid deletion of Vdr 1,25(OH) 2 D 3 and its receptor play a role in host defense mechanisms by modulating antimicrobial peptides (18) . We evaluated the transcript levels of Defb1, an antimicrobial peptide secreted by IECs, in the mucosa of healthy and DSS-treated transgenic mice. Defb1 expression was significantly elevated in the colon descendens of Vdr 2/2 mice before and after DSS insult [P , 0.01; Fig. 8(a) ]. In Vdr int2 mice, we observed no differences in Defb1 expression in the colon descendens of healthy or diseased mice compared with their Vdr int+ littermates [ Fig. 8(b) ]. However, mice with a myeloid Vdr deletion demonstrated increased Defb1 expression in the colon descendens after DSS-induced colitis compared with their Vdr myel+ littermates [P , 0.05; Fig. 8(c) ] and, similar to Vdr 2/2 mice, this trend was already visible in the mucosa of healthy Vdr myel2 mice [ Fig. 8(e) ].
Finally, we assessed the amount of bacteria present in the mucosa of healthy mice as measured by the amount of 16S ribosomal DNA. Mice with a systemic Vdr deletion had a significantly greater bacterial load in their mucosa 
Discussion
Epidemiological studies have previously established the association between vitamin D 3 levels and quality of life or disease activity in IBD patients (1) . The importance of Vdr expression during gut inflammation is demonstrated in several studies using systemic Vdr KO mice, which showed that these mice are more sensitive to models of experimental colitis (5) . To better understand the contribution of VDR signaling in the different cells of the gut to this disease, we investigated the effects of intestinalspecific or myeloid Vdr deletion in parallel with systemic Vdr 2/2 mice using a model of DSS-induced colitis. The , and Vdr myel2 mice and their WT littermates after DSS-induced colitis (7-day protocol). Results are expressed as mean 6 standard error of mean (n $ 7). *P , 0.05. chemical compound DSS disrupts the epithelial barrier, allowing direct contact between luminal contents and the deeper layers of the bowel wall, which subsequently attracts immune cells that massively produce proinflammatory cytokines. In accordance with other reported findings (5), Vdr 2/2 mice exhibited worse clinical and histological manifestations compared with Vdr +/+ mice after DSS insult. The exacerbated clinical symptoms in Vdr 2/2 mice were accompanied by increased expression of several proinflammatory cytokines in the mucosa of the distal colon. Even with the DSS insult, expression levels of anti-inflammatory cytokines such as Il-4 and Il-10 were undetectably low in the colonic mucosa of these mice (data not shown). In contrast, mice with an intestinal Vdr deletion did not exhibit worsened clinical or histological characteristics compared with their WT littermates. Although no differences in clinical parameters were observed between Vdr int2 and Vdr int+ mice with colitis, we detected a tendency toward augmented levels of proinflammatory cytokine expression in the colonic mucosa of Vdr int2 mice compared with Vdr int+ mice. Our results differ from those of other studies that investigated intestinal Vdr expression during colitis. Those studies demonstrated that loss or overexpression of intestinal Vdr expression, respectively, worsened or ameliorated symptoms in models of experimental colitis and suggested increased mucosal permeability, increased intestinal epithelial cell apoptosis, increased mucosal bacterial load, and defects in autophagy as potential causes of the aggravated colitis symptoms (19) (20) (21) . In the present study, healthy Vdr int2 mice did not exhibit increased bacterial loads in the colon, in contrast to systemic Vdr 2/2 mice that held significantly more bacterial DNA in their noninflamed mucosa. When expression of several tight junction proteins (claudins) and E-cadherin, an adherens junction protein, was investigated in healthy and diseased mice, no differences between Vdr int2 and their WT littermates were observed (data not shown). Moreover, we assessed ATG16L1 protein expression in the ileum of healthy Vdr int2 and Vdr int+ mice as a marker for autophagy. No differences in ATG16L1 expression were observed between Vdr int2 and their WT littermates (data not shown). The lack of differences in autophagy and permeability in the gut between the Vdr int2 and Vdr int+ mice might partly explain why these mice did not exhibit more severe symptoms after experimental colitis induction. In contrast to other studies, all the mice in the present study were maintained with a high lactose, high calcium/phosphate diet to overcome the bone phenotype of Vdr 2/2 and Vdr int2 mice (12) . High calcium levels in the diet are known to inhibit the severity of colitis https://academic.oup.com/endosymptoms (22) . To exclude the effects of the high lactose, high calcium diet on DSS susceptibility of Vdr int2 mice, we performed preliminary experiments with Vdr int2 and Vdr int+ littermates consuming a normal diet and found that the Vdr int2 mice were not more susceptible to DSSinduced colitis compared with the Vdr int+ mice in this condition (data not shown). Other groups investigating the effect of intestinal Vdr expression during intestinal inflammation used higher DSS concentrations. Therefore, we performed a preliminary experiment in which mice were administered 5% DSS for 7 days; however, no differences in clinical disease symptoms were observed between the Vdr int2 and Vdr int+ mice (data not shown). Hence, our results suggest that neither the rescue diet nor the DSS concentration was responsible for the lack of differences between the Vdr int2 and Vdr int+ mice. Other confounding causes for different DSS responses include environmental factors such as different husbandry conditions and, subsequently, dissimilar microbiota. Because it has been argued that differences in the bacterial community can be explained by maternal transmission (23) and strong littermate effects were observed after DSS induction, we strictly used WT littermates as controls in our experiments. During intestinal inflammation, activated neutrophils and macrophages infiltrate the intestinal mucosa where they produce large amounts of reactive oxygen species, which contribute to the development of IBD. Cells possess an antioxidant defense system that consists of enzymes and scavenger molecules (16) . In several animal models of experimental colitis, oxidative stress markers are upregulated (24) , and our results confirmed this. Expression of Gpx-2, an enzyme responsible for clearance of hydrogen peroxide in the gut that is specifically expressed in epithelial cells, increased in the colon after DSS insult. However, no significant differences were observed between Vdr 2/2 , Vdr int2 , or Vdr myel2 mice and their WT littermates, suggesting that Vdr deletion did not contribute to major changes in Gpx-2 expression.
To our knowledge, our study is the first to investigate the effects of Vdr deletion in macrophages and granulocytes during DSS-induced colitis. Innate immune cells play a central role during DSS colitis, because mice lacking T-and B-cells still develop colitis on receiving DSS (25) , making this model of particular interest to study innate immune cells. Moreover, numerous IBD susceptibility single nucleotide polymorphisms have been identified that affect innate immune cell function (26) . Resident intestinal macrophages are tolerant immune cells with potent phagocytic and bactericidal features without secreting proinflammatory cytokines. However, in the case of inflammation, newly recruited monocytes differentiate into macrophages that produce proinflammatory cytokines.
Despite the lack of a clear difference in clinical parameters between Vdr myel2 and Vdr myel+ mice, several proinflammatory cytokines were highly upregulated in the colon of the Vdr myel2 mice after DSS-induced colitis, suggesting the involvement of other (immune) cell types in the clinical manifestation of colitis. In addition, because most proinflammatory cytokines were markedly increased in Vdr myel2 mice, we speculate that Vdr expression in macrophages is important for controlling initial intestinal immune responses during gut inflammation. Intestinal macrophages have been reported to drive the in vitro differentiation of T-helper 17 cells (27) , and more T-helper 17 cells are generated in the absence of VDR (28) . In accordance with these findings, we observed a clear increase in mucosal Il-17 expression after DSS-induced colitis in mice with a Vdr deletion in macrophages. Another study demonstrated increased interleukin (IL)-6 production in peritoneal macrophages of systemic Vdr 2/2 mice (29). Significantly elevated Il-6 transcript levels were also observed in the colonic mucosa of Vdr myel2 mice during experimental colitis, further suggesting the proinflammatory state of Vdr-deficient immune cells.
Vdr myel2 mice were marginally more susceptible to DSS, albeit not to the extent of systemic Vdr KO mice, implying the importance of VDR expression in other cell types during intestinal inflammation. Because Vdr myel2 mice still express VDR in their T-cells, B-cells, and most dendritic cells, it is possible that VDR expression in these cells is more crucial for protection against uncontrolled gut inflammation. Other groups have already shown that the function of many different types of T-cells is regulated by vitamin D 3 and that T-cells from systemic Vdr 2/2 mice exhibit a more pathogenic phenotype than Vdr +/+ T-cells (30) (31) (32) . We observed greater levels of Defb1 in the colon descendens of Vdr 2/2 and Vdr myel2 mice, although the transcript levels of Defb1 remained unchanged in Vdr int2 mice compared with their WT littermates. Defb1 encodes the protein b-defensin-1, an antimicrobial peptide constitutively secreted by IECs. Mice with a defect in and Vdr myel+ mice consuming regular drinking water and after 2.5% DSS administration. Results are expressed as mean 6 standard error mean on a logarithmic scale (n $ 5). *P , 0.05. doi: 10.1210/en.2017-00139 https://academic.oup.com/endob-defensin-1 show a reduced increase of IL-17 when infected with Candida (33). Moreover, it has been shown that IL-17 is able to augment other b-defensins such as murine b-defensin-3 (34) and human b-defensin-2 (35) . Therefore, it is tempting to speculate that increased Il-17 levels are associated with augmented Defb1 expression in the colon of systemic Vdr and myeloid-specific Vdr KO mice. However, more research is necessary to decipher the link among vitamin D 3 , the immune system, and the antimicrobial response of IECs.
In conclusion, we found that the loss of intestinal Vdr expression had no effects on clinical parameters in our model of acute DSS-induced colitis and did not manifestly change cytokine or antimicrobial peptide expression. In contrast, loss of Vdr expression in macrophages and granulocytes marginally affected DSS-associated symptoms but resulted in increased mucosal proinflammatory cytokine expression. These data suggest a role for innate immune cell vitamin D 3 /VDR signaling in controlling gut inflammation and that VDR signaling in cells other than 
